Piper Jaffray Raises Price Target on Envision Healthcare (EVHC) Following 2Q EPS Beat
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Envision Healthcare Enters Definitive Agreement to Acquire Rural/Metro
July 30, 2015 4:06 PM EDTGREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Holdings, Inc. (NYSE: EVHC) (Envision), has entered into a definitive agreement to acquire Rural/Metro Corporation (Rural/Metro) through its medical transportation segment American Medical Response (AMR). This pending acquisition enhances Envisions mobile integrated healthcare delivery capability, a key component of its care coordination model amongst its pre-hospital, acute care and post-acute care services.
Rural/Metro is expected to generate annualized 2015 revenue of approximately $600 million. Upon closing, the transaction is expected to be accretive to Envisions earnings. The pending acquisition is subject to regulatory... More
Envision Healthcare Reports Second Quarter Adjusted EBITDA of $162.8 Million, up 21% on Strong Revenue Growth and Adjusted EPS Increases by 32%
July 30, 2015 4:05 PM EDTGREENWOOD VILLAGE, Colo.--(BUSINESS WIRE)-- Envision Healthcare Holdings, Inc. (Envision or Company) (NYSE: EVHC) reported results from operations for the three months and six months ended June 30, 2015. All comparisons included in this release are for the 2015 periods to the comparable 2014 period, unless otherwise noted.
Highlights:
Net revenue increased by 25.9% to $1.35 billion; Adjusted EBITDA grew by 20.5% to $162.8 million; Net income was $52.4 million, compared to a net loss of $2.0 million; Adjusted EPS was $0.37, an increase of 32%,... More